GlassScriptPhysician profile
Angizeh Sadeghi
NPI 1538211917
$3,668.91
in general payments reported to CMS, 2019-2025
21 companies · $514 in 2025
The $514 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $348 · 2021: $439 · 2022: $989 · 2023: $171 · 2024: $832 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $661.14 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $572.33 | 2019-2025 | Trulance, Xifaxan, Plenvu |
| Abbvie INC. | $439.50 | 2020-2025 | Creon |
| Takeda Pharmaceuticals U.S.A., INC. | $342.82 | 2019-2025 | Entyvio |
| Lilly USA, LLC | $328.08 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $254.85 | 2021-2025 | Wegovy, Ozempic |
| Ardelyx, INC. | $222.49 | 2024-2025 | Ibsrela |
| Qol Medical, LLC | $170.12 | 2020-2025 | Sucraid, Sucraid |
| Allergan, INC. | $125.26 | 2019 | |
| Redhill Biopharma INC. | $104.94 | 2020-2023 | Talicia |
| Gilead Sciences, INC. | $82.75 | 2020 | |
| Revance Therapeutics, INC. | $72.28 | 2024 | Daxxify |
| Daiichi Sankyo INC. | $51.32 | 2019-2020 | |
| Pfizer INC. | $46.43 | 2021-2025 | |
| Lundbeck LLC | $42.39 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $36.26 | 2025 | |
| Nestle Healthcare Nutrition INC. | $32.65 | 2021 | |
| Ironwood Pharmaceuticals, INC | $26.81 | 2024 | |
| Exact Sciences Corporation | $21.65 | 2024 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $19.49 | 2024 | Sutab, Suflave |
| Olympus America INC. | $15.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angizeh Sadeghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.